Tocilizumab improves remission rates in giant-cell arteritis: The GiACTA trial
1. The addition of tocilizumab, a monoclonal antibody against interleukin-6 (IL-6), to a glucocorticoid taper sustained remission in patients with ...
Tag: Temporal Arteritis
Patient Basics: Giant Cell Arteritis (Temporal Arteritis)
Originally published by Harvard Health. What Is It? Giant cell arteritis, also called temporal arteritis, is a disease in which ...